Showing results (11-20 of 468) with videos related to
Sort By:
Pageof 47
Statistical Methods in Medical Research|February 21, 2008
Surrogate endpoints for overall survival in early colorectal cancer from the clinician's perspectiveAxel GrotheySeminars in Oncology|December 6, 2006
Future directions in vascular endothelial growth factor-targeted therapy for metastatic colorectal cancerAxel GrotheySeminars in Oncology|December 21, 2006
Is there a third-line therapy for metastatic colorectal cancer?Axel GrotheyOncology|March 31, 2011
Reintroduction of oxaliplatin: a viable approach to the long-term management of metastatic colorectal cancerAxel GrotheyNature Clinical Practice. Oncology|October 30, 2008
A comparison of XELOX with FOLFOX-4 as first-line treatment for metastatic colorectal cancerAxel GrotheyClinical Colorectal Cancer|January 24, 2007
Commentary on a phase III trial of bevacizumab plus XELOX or FOLFOX4 for first-line treatment of metastatic colorectal cancer: the NO16966 trialPreeta Tyagi, Axel GrotheyOncotargets and Therapy|October 29, 2015
Molecular profiling in the treatment of colorectal cancer: focus on regorafenibYiyi Yan, Axel GrotheyExpert Review of Anticancer Therapy|November 27, 2012
Treatment options for advanced pancreatic cancer: a reviewRahma Warsame, Axel GrotheyTherapeutic Advances in Medical Oncology|November 3, 2012
Antiangiogenesis therapy in the treatment of metastatic colorectal cancerAxel Grothey, Carmen AllegraExpert Opinion on Pharmacotherapy|November 13, 2015
Regorafenib in the treatment of colorectal cancerNeil Majithia, Axel GrotheyPageof 47